ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1844

$1.68M Total Retail Price of All Prescriptions

Rank: 7 out of 1844

713 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 713 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 713 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 28,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 1,199 1,109 1 1
FUROSEMIDE 1,098 1,042 2 7
POTASSIUM CHLORIDE 1,093 1,042 3 16
WARFARIN SODIUM 940 829 4 13
AMLODIPINE BESYLATE 816 773 5 6
HYDROCODONE-ACETAMINOPHEN 769 651 S3 6 2
LISINOPRIL 766 704 7 4
SIMVASTATIN 722 625 8 3
DONEPEZIL HCL 718 705 9 26
METOPROLOL TARTRATE 694 644 10 11
OMEPRAZOLE 587 525 11 5
MIRTAZAPINE 582 557 12 49
TRAZODONE HCL 560 517 13 43
NAMENDA 556 538 14 33
CITALOPRAM HBR 555 539 15 19
CYMBALTA 501 437 16 36
TORSEMIDE 497 476 17 118
GABAPENTIN 482 403 18 15
SERTRALINE HCL 458 408 19 21
DIVALPROEX SODIUM 392 372 20 74
CARVEDILOL 388 354 21 22
METOPROLOL SUCCINATE 387 349 22 14
IPRATROPIUM-ALBUTEROL 356 327 23 113
PANTOPRAZOLE SODIUM 354 330 24 32
TRAMADOL HCL 353 342 25 18
POLYETHYLENE GLYCOL 3350 298 276 26 39
LANTUS 297 250 27 42
RISPERIDONE 284 273 28 65
TAMSULOSIN HCL 278 239 29 27
QUETIAPINE FUMARATE 271 235 30 82
HUMALOG 247 212 31 114
LEVOFLOXACIN 239 219 32 78
LOSARTAN POTASSIUM 231 225 33 24
CARBIDOPA-LEVODOPA 224 220 34 86
PRAVASTATIN SODIUM 220 193 35 10
RANITIDINE HCL 209 207 36 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 198 165 37 73
METFORMIN HCL 197 166 38 8
ATORVASTATIN CALCIUM 193 177 39 12
ALLOPURINOL 179 142 40 29
OLANZAPINE 177 155 41 117
PREDNISONE 174 166 42 40
FENTANYL 171 102 S2 43 66
NOVOLOG 164 124 44 84
HYDROCHLOROTHIAZIDE 163 131 45 9
GLIPIZIDE 159 155 46 70
ROPINIROLE HCL 158 111 47 76
BUSPIRONE HCL 158 130 47 127
CEPHALEXIN 155 146 49 56
CLOPIDOGREL 153 150 50 34
ADVAIR DISKUS 153 136 50 51
AMOX TR-POTASSIUM CLAVULANATE 151 148 52 139
CLONIDINE HCL 146 137 53 64
BACLOFEN 142 97 54 119
DIGOXIN 142 130 54 67
DIOVAN 137 118 56 58
KLOR-CON M20 135 123 57 54
TRICOR 134 130 58 109
EXELON 130 128 59 112
LYRICA 129 76 60 92
NYSTATIN 125 111 61 85
LIDODERM 125 117 61 155
CEFTRIAXONE 119 113 63 213
ATENOLOL 117 109 64 17
CIPROFLOXACIN HCL 116 103 65 62
ESCITALOPRAM OXALATE 109 106 66 52
ISOSORBIDE MONONITRATE ER 106 105 67 59
SPIRONOLACTONE 106 106 67 60
OXYCODONE HCL 105 82 S2 69 104
LEVETIRACETAM 105 79 69 105
DIVALPROEX SODIUM ER 102 102 71 180
OXYBUTYNIN CHLORIDE ER 100 83 72 126
PLAVIX 99 96 73 61
FAMOTIDINE 99 76 73 63
NITROFURANTOIN MONO-MACRO 96 91 75 151
FINASTERIDE 94 89 76 137
SEROQUEL 93 78 77 191
SPIRIVA 92 76 78 57
METOCLOPRAMIDE HCL 91 87 79 148
HYDRALAZINE HCL 90 87 80 120
CRESTOR 85 78 81 30
LACTULOSE 85 85 81 171
OXYCONTIN 83 69 S2 83 144
DILTIAZEM 24HR CD 83 83 83 132
VENLAFAXINE HCL ER 81 52 85 93
DOXAZOSIN MESYLATE 80 80 86 110
OXYCODONE HCL-ACETAMINOPHEN 78 14 S2 87 83
FENOFIBRATE 77 64 88 71
METRONIDAZOLE 75 67 89 311
VENLAFAXINE HCL 73 60 90 262
OXYCODONE-ACETAMINOPHEN 72 65 S2 91 94
IBUPROFEN 72 60 91 89
PROMETHAZINE HCL 72 53 R 91 88
LIDOCAINE HCL 71 68 94 270
BUPROPION XL 70 58 95 190
METOLAZONE 70 70 95 209
NIASPAN 70 52 95 162
LOPERAMIDE 70 58 95 216
ZOLPIDEM TARTRATE 68 64 99 23
ALENDRONATE SODIUM 68 57 99 25
NEXIUM 66 55 101 31
DOXYCYCLINE HYCLATE 62 56 102 90
PAROXETINE HCL 62 45 102 68
ENOXAPARIN SODIUM 61 40 104 240
SANTYL 61 47 104 259
HYDROCORTISONE 60 59 106 242
FLUTICASONE PROPIONATE 60 42 106 50
VESICARE 59 59 108 182
CILOSTAZOL 59 58 108 235
JANUVIA 58 56 110 77
DILTIAZEM ER 56 55 111 200
ONDANSETRON HCL 56 46 111 267
RENVELA 55 34 113 431
KETOCONAZOLE 55 49 113 231
MORPHINE SULFATE 54 51 S2 115 207
BUDESONIDE 53 47 116 330
NITROGLYCERIN PATCH 52 52 117 173
DILTIAZEM HCL 51 43 118 221
ZETIA 51 45 118 81
GLIPIZIDE ER 50 50 120 79
FLUOXETINE HCL 50 41 120 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.